From qualification to connectivity: the trends changing pharma packaging expectations

From decentralised care to RFID-enabled traceability, the demands on pharmaceutical labels are multiplying.

Patient care is shifting. Therapies are more targeted, timelines are tighter and global regulations continue to evolve. As new formats enter the supply chain and the pressure to get drugs to market increases, labels are expected to do more, perform better and integrate smarter.

In pharma, labels are one of the most critical and tightly controlled packaging components. A small tweak to the adhesive, the facestock or even the liner can trigger requalification work or full material revalidation. Qualification cycles in pharma often take months or even years, requiring a long-term approach. A label selected today may still be in use ten years from now, which puts enormous weight on performance, compliance and consistent supply.

From clinic to home: how patient-led care is impacting packaging

Pharmaceutical packaging used to be built for hospital floors and clinical settings. Now it needs to deliver in living rooms, bathroom cabinets and the hands of everyday users. As more treatments shift toward self-administration — via auto-injectors, wearables or prefilled devices — labels are being asked to do more.

Designing for home use is completely different. This is not a controlled environment with trained professionals. The label has to survive real-world handling — friction, moisture, everyday knocks — and still stay legible and secure.

In this context, the label becomes a user interface. It might authenticate the product, guide someone through dosing or connect them to digital instructions via smartphone.

This is where intelligent labels, particularly those with Near Field Communication (NFC), are starting to play a role. NFC is a type of Radio Frequency Identification (RFID) technology designed for close-range interaction — most commonly known through contactless payments. Applied to pharmaceuticals, it can allow patients to tap their phone against a label to authenticate the product, access electronic product information (ePI) leaflets, usage guidance or adherence tools. This is especially important in chronic therapies, where only around 50% of patients follow their prescriptions correctly.

At the same time, manufacturers are exploring Ultra High Frequency (UHF) RFID — a long-range variant used to track inventory through the supply chain. While NFC supports patient interaction, UHF is better suited to improving operational oversight, offering visibility from production to point-of-care.

Pharma customers say that the packaging experience has to work harder and not just to deliver the drug, but to support the person taking it. That includes everything from tactile feel to digital functionality.

Making traceability work in a more connected, decentralised supply chain

As self-administered treatments grow, so does the need for precise, reliable traceability. Not only to protect products, but to manage supply more efficiently. And there is a very specific and growingly popular technology that is playing a growing role.

The industry is still in the early phases of RFID adoption in pharma, but momentum is building. Much of the demand comes from manufacturers and healthcare providers who want better visibility, fewer errors and faster response times.

In hospital settings, RFID-tagged products are helping staff save time by streamlining inventory and recall processes. Case studies have shown that the manual work involved in verifying products during recalls can cost hospitals thousands of dollars annually in staff time alone. Because UHF RFID provides instant, unit-level traceability, it eliminates the need for time-consuming location checks — recovering over 90% of that effort and effectively removing the labor burden from recalls.

The technology is also being explored in pharmaceutical manufacturing for more accurate unit level traceability, which is crucial for preventing batch segregation and mix-up risks in complex and high-speed fill-finish manufacturing operations. It’s not just about traceability for safety but it’s also about resource use. Roughly 4% of pharmaceutical production is wasted (which translates to a loss of over $11 billion) and RFID gives us tools to reduce that, track expiry and respond faster.

Packaging as a platform: integrating intelligence and information

As expectations for what packaging can do continue to grow, labels are evolving into something more: a platform that bridges the physical and digital worlds. They're no longer just functional components, but smart surfaces that carry information, connect systems and support users at every stage.

More customers are asking manufacturers to build in functionality that goes beyond identification. They want labels that engage patients, guide dosage, confirm authenticity and even provide feedback after use — often within the same construction.

That’s a big ask. But it reflects a growing recognition that packaging plays a far greater role than holding a product. In under-resourced regions, for example, smart features like NFC can help verify authenticity or deliver digital instructions without relying on complex infrastructure.

According to the WHO, roughly 10%of medicines in low- and middle-income countries are substandard or falsified. These labels can offer a layer of protection and guidance where traditional systems might not reach.

It also means materials must hold up under real pressure. Labels need to survive sterilisation, freezing, transport and more while remaining readable and functional on different lines, printers and formats. That’s what makes qualification such an imperative part of development.

Balancing performance and sustainability under mounting pressure

As expectations grow around what pharmaceutical packaging must do, sustainability is becoming harder to separate from performance. While patient safety remains non-negotiable, there’s growing pressure to reduce environmental impact, and labels are increasingly part of that conversation.

More customers are looking for ways to reduce material use and waste without compromising on compliance or performance. That is especially true for small-diameter containers like vials and syringes, where you need reliable adhesion on curved surfaces and resistance to cold or humid storage conditions.

Many companies are exploring thinner materials, mono-material constructions or recyclable label designs. But those changes come with dependencies. It’s never just about finding a more sustainable material, one has to understand how it behaves with adhesives, application lines, packaging formats and print methods.

This systems-level approach is becoming essential, especially as the Packaging and Packaging Waste Regulation (PPWR) begins to reshape expectations across the European market. While some exemptions for primary pharma packaging still apply, brands are expected to demonstrate recyclability and make data-backed choices. That’s where digital features like NFC are gaining traction. When you can’t easily change the physical packaging due to regulation, the digital layer becomes an invaluable tool. NFC helps reduce waste, improve accountability and extend value across the product lifecycle — from manufacturing and inventory to patient use and end-of-life sorting.

The environmental impact of autoinjectors, for example, is largely driven by raw material and end-of-life disposal. NFC enables interventions without altering the container itself, such as switching to ePI, verifying authenticity, tracking adherence or enabling sorting and recycling via a unique digital identity. Still, the path isn’t always straightforward. Sometimes a more sustainable material fails to meet the technical or regulatory standards required or it behaves differently across packaging lines in different countries. That’s where testing and collaboration matter most.

Balancing sustainability, functionality and compliance is already complex — but it’s only half the picture. As more labels integrate digital features like RFID technology, the performance requirements become even more precise.

Why qualification matters more than ever

That’s where qualification becomes critical. When digital and physical elements come together, the margin for error narrows. A slight shift in adhesive, a misaligned inlay or a mismatched surface can throw off everything from line speed to scan accuracy.

Customers should be urged to take a lifecycle view. Ask early: how long will the label be in use? How is it stored? What does the regulatory path look like? What printing methods are in play?

Harmonisation is also key. A label qualified for one market often needs to be replicated across multiple regions, each with its own standards, packaging lines and documentation.

Throw RFID into the mix and there’s even more to consider. There is still a misconception that RFID will not work on small-diameter vials or high-speed lines, but with the right inlay, adhesive and placement, it absolutely can. That requires early integration between packaging engineers, material experts and system architects. Getting the label right from the beginning saves time down the line — fewer delays, less rework, better outcomes.

Behind every pharmaceutical label is a network of decisions that carry real-world consequences. From ensuring patient safety and data accuracy to enabling traceability across global supply chains, the stakes are high — and rising. As treatments grow more complex and administration moves closer to the patient, the need for smart, reliable, well-qualified packaging solutions becomes increasingly important. Getting the details right isn’t just about efficiency, but about trust, safety and building systems that deliver when it matters most.

Get in touch

If you would like to learn more about our pharmaceutical labeling portfolio, please do not hesitate to contact our team. We serve this industry every day and are happy to assist you in solving your challenges. Click here to contact us today and let's take the first step towards overcoming your labeling obstacles together.

Materials

Types of packaging

Digital

Tools

Services

From qualification to connectivity: the trends changing pharma packaging expectations

From clinic to home: how patient-led care is impacting packaging